V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310008168 | 310009947 | null | null | Palliative (P) | 2015-01-09 | 2015-01-10 | INOVATYON Trial | null | null | 310024973 | CVP R |
| 310008169 | 310008330 | 1.62 | 50 | null | 2017-06-25 | 2017-06-27 | Cisplatin + Docetaxel +Fluorouracil | N | N | 310024987 | VEMURAFENIB |
| 310008170 | 310005300 | 1.53 | 86.2 | Adjuvant (A) | 2015-07-29 | 2015-09-09 | Olaparib | 02 | N | 310024988 | EPIRUBICIN |
| 310008172 | 310008333 | 0 | 61 | Palliative (P) | 2017-02-22 | 2017-02-22 | Cytarabine+Methotrexate Intrathecal | null | null | 310025017 | MVAC |
| 310008173 | 310008334 | 1.7 | 58.8 | Palliative (P) | 2015-11-11 | 2015-11-20 | ICE + GCSF | N | N | 310025048 | ICE-R |
| 310008174 | 310005307 | 1.59 | 61.1 | Palliative (P) | 2015-04-30 | 2015-05-12 | Pentostatin | N | N | 310025049 | TOPOTECAN |
| 310008175 | 310009948 | 1.67 | 64 | null | 2016-09-04 | 2016-09-07 | CAPECITABINE + CARBOPLATIN | 02 | N | 310025049 | BENDAMUSTINE |
| 310008176 | 310005308 | 1.64 | 53.75 | Palliative (P) | 2018-05-24 | 2018-05-24 | Azacitidine | N | N | 310025087 | THALIDOMIDE |
| 310008177 | 310005310 | 1.92 | 111 | Curative (C) | 2013-10-18 | 2013-10-21 | Pemetrexed | N | N | 310025087 | IPO |
| 310008178 | 310005310 | 1.78 | 96.4 | Adjuvant (A) | 2015-04-23 | 2015-04-23 | Abiraterone | N | N | 310025087 | POUT TRIAL |
| 310008179 | 310005311 | 1.67 | 56.7 | Curative (C) | 2014-05-20 | 2014-10-01 | BCG Intravesical | 2 | N | 310025109 | GEMCITABINE + OXALIPLATIN |
| 310008180 | 310005312 | null | 63.3 | Palliative (P) | 2016-12-04 | 2017-01-05 | BCG Intravesical | N | N | 310025119 | CISPLATIN + PEMETREXED |
| 310008181 | 310005313 | null | null | Palliative (P) | null | 2013-07-14 | THALIDOMIDE | 02 | null | 310025127 | BLEOMYCIN |
| 310008182 | 310005315 | 0 | null | Curative (C) | 2017-05-04 | 2017-05-08 | Bortezomib +/- Dexamethasone | N | N | 310025143 | CETUXIMAB + RT |
| 310008183 | 310005315 | 1.87 | 61.4 | Neo-adjuvant (N) | 2016-02-10 | 2016-02-13 | POMALIDOMIDE | N | N | 310025143 | NIVOLUMAB |
| 310008184 | 310005315 | 1.57 | 66.5 | Palliative (P) | 2013-06-02 | 2013-06-02 | Capecitabine (21 day) + Irinotecan | 02 | N | 310025143 | BENDAMUSTINE |
| 310008185 | 310008338 | null | 85.6 | Neo-adjuvant (N) | 2016-03-24 | 2016-03-25 | RITUXIMAB + prednisolone + VINBLASTINE + prednisolone | N | N | 310025161 | IMATINIB |
| 310008186 | 310008338 | 1.81 | null | Palliative (P) | 2016-08-26 | 2017-01-30 | Trabectedin | N | N | 310025161 | PMITCEBO |
| 310008187 | 310005317 | 1.71 | null | Curative (C) | 2017-04-02 | 2017-10-25 | Oxaliplatin + Modified de Gramont | 2 | N | 310025179 | DOXORUBICIN |
| 310008188 | 310005319 | 1.58 | 53 | Palliative (P) | 2014-10-12 | 2014-10-23 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 310025194 | TRABECTEDIN |
| 310008189 | 310005320 | 1.64 | 74.1 | Palliative (P) | null | 2015-05-08 | Cyclophosphamide Fludarabine (Oral) | N | N | 310025196 | CETUXIMAB + RT |
| 310008190 | 310005321 | null | 47.2 | Palliative (P) | 2016-05-17 | 2016-06-04 | VAC | null | null | 310025197 | ICE |
| 310008191 | 310005321 | 1.73 | 0 | Disease modification (D) | 2016-07-26 | 2016-07-30 | LENALIDOMIDE | null | null | 310025197 | BEAM + FLUDARABINE |
| 310008192 | 310005324 | 1.85 | null | Neo-adjuvant (N) | 2017-01-14 | 2017-05-07 | Alemtuzumab(INTRAVENOUS) | 2 | N | 310025212 | CETUXIMAB |
| 310008193 | 310005324 | 1.54 | null | Palliative (P) | 2015-01-09 | 2015-01-11 | Trabectedin | N | null | 310025212 | MTX HD + PROCARBAZINE + VINCRISTINE |
| 310008194 | 310008344 | 1.81 | 66 | Palliative (P) | 2015-05-24 | 2015-06-29 | CTD (Thalidomide 200mg) | N | N | 310025231 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 310008195 | 310008344 | 1.8 | 68.8 | Neo-adjuvant (N) | null | 2013-11-29 | IVE + METHOTREXATE | N | N | 310025231 | OLAPARIB |
| 310008196 | 310008344 | 1.76 | 80.7 | Curative (C) | 2015-03-01 | 2015-05-05 | NIVOLUMAB | N | N | 310025231 | METHOTREXATE |
| 310008197 | 310005326 | 1.63 | 71.3 | Palliative (P) | 2015-06-06 | 2015-06-06 | DABRAFENIB | N | N | 310025252 | FEC + DOCETAXEL |
| 310008198 | 310005326 | 1.59 | 28.2 | Palliative (P) | 2015-03-18 | 2015-03-19 | Imatinib 400mg | N | N | 310025252 | RMS 2005 TRIAL |
| 310008199 | 310005326 | 1.26 | 78.6 | Curative (C) | 2013-04-30 | 2013-04-30 | RCEOP | N | N | 310025252 | CYTARABINE |
| 310008200 | 310005332 | 1.57 | 0 | Curative (C) | 2013-04-20 | 2013-05-21 | FLUOROURACIL + MITOMYCIN | N | N | 310025292 | TRASTUZUMAB |
| 310008201 | 310005333 | null | null | Neo-adjuvant (N) | 2013-10-19 | 2013-12-01 | STS Rhabdo RMS 2005 Vin Cyclo | N | null | 310025319 | ICON TRIAL |
| 310008202 | 310008346 | 1.6 | null | null | 2013-01-08 | 2013-05-02 | Azacitidine | Y | N | 310025333 | CISPLATIN + TOPOTECAN |
| 310008203 | 310008347 | 1.75 | 83.3 | Palliative (P) | 2015-10-07 | 2015-10-07 | Trastuzumab 21 day maintenance | 02 | N | 310025333 | TRABECTEDIN |
| 310008204 | 310005342 | 1.7 | 109.7 | Curative (C) | 2015-03-14 | 2015-03-24 | PEG INTERFERON | N | null | 310025341 | R-GEM-P |
| 310008205 | 310009957 | 1.73 | 69.9 | Palliative (P) | 2017-11-03 | 2018-05-21 | TOPOTECAN | N | null | 310025352 | ATG |
| 310008206 | 310005343 | 1.71 | null | Palliative (P) | 2015-11-23 | 2015-11-24 | Bortezomib + Cyclophos + Dex | N | N | 310025360 | CYTARABINE INTRATHECAL |
| 310008207 | 310005343 | 1.76 | 77.8 | null | 2016-03-31 | 2016-05-19 | Cytarabine+Methotrexate Intrathecal | N | N | 310025360 | TRIPLE INTRATHECAL |
| 310008208 | 310005344 | 1.59 | null | null | 2018-04-13 | 2018-04-13 | BCG Intravesical | N | N | 310025385 | DOXORUBICIN + IFOSFAMIDE |
| 310008209 | 310005346 | null | null | Palliative (P) | 2014-04-08 | 2014-04-09 | Trabectedin | 2 | null | 310025395 | BCG |
| 310008210 | 310005347 | 1.62 | 99.4 | Palliative (P) | 2017-11-08 | 2017-11-08 | PEG INTERFERON | N | null | 310025400 | DABRAFENIB + TRAMETINIB |
| 310008211 | 310008352 | 1.72 | null | Palliative (P) | 2015-05-03 | 2015-05-03 | Cisplatin + Etoposide (5 day) | 02 | null | 310025400 | BEVACIZUMAB + IRINOTECAN + MDG |
| 310008212 | 310008353 | 0 | 61.1 | Palliative (P) | 2016-05-08 | 2016-06-11 | Capecitabine + Cisplatin | 2 | N | 310025414 | EMA |
| 310008213 | 310005351 | 1.6 | 52.8 | Adjuvant (A) | 2014-06-07 | 2014-06-14 | CISPLATIN + VINORELBINE | 2 | N | 310025420 | CAV |
| 310008214 | 310008355 | 1.79 | 82 | Palliative (P) | 2015-02-14 | 2015-02-14 | Temozolomide 200mg/m2 | null | N | 310025478 | ESPAC TRIAL |
| 310008215 | 310005355 | 0 | 107.2 | Adjuvant (A) | 2014-07-19 | 2014-07-19 | Irinotecan + Modified De Gramont | 2 | N | 310025484 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 310008216 | 310005356 | 1.56 | 61.3 | Palliative (P) | 2016-12-26 | 2017-01-02 | Carboplatin + Docetaxel | N | N | 310025484 | CHLORAMBUCIL |
| 310008217 | 310005356 | 1.62 | 40.1 | Not known (9) | 2016-06-24 | 2016-06-24 | Imatinib 400mg | 02 | N | 310025484 | FLUDARABINE |
| 310008218 | 310005357 | 1.83 | null | null | null | 2014-06-15 | Sunitinib | null | null | 310025516 | BEAM + FLUDARABINE |